Improvement of stage 1 hypertension by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial
- Conditions
- Stage 1 Hypertension
- Registration Number
- ITMCTR1900002511
- Lead Sponsor
- Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the diagnostic criteria for stage 1 hypertension;
2. Age between 35 and 65 years old;
3. No language and mental retardation, can successfully answer and fill out the questionnaire;
4. Voluntary signing of informed consent.
1. Contraindications for the use of acupoint stimulators: wearing a pacemaker and other implanted medical devices; suffering from acute diseases, infectious diseases, malignant tumors;cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction or other malignant diseases; scars, bruises, scratches or inflammation on the skin of the acupuncture points.
2. Hypertension caused by other vascular diseases, primary aldosteronism, other endocrine hypertension, and secondary hypertension caused by other causes.
3. Receiving drugs that affect blood pressure except antihypertensive drugs in previous 2 months such as glucocorticoids, central nervous system inhibitors.
4. Uncontrolled diabetes.
5. Receiving acupuncture treatment in previous 1 month.
6. Drug or alcohol abuse.
7. Pregnant women or women in lactation period.
8. Joined any other study in process.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method